ORTEXORTEX News
Tracking HSY? Get live short interest, options flow, and signals on ORTEX.Sign up free →
HS
Trader NoteHSY

Hershey Bounces but the Street Has Already Moved On

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 31 Oct 2026, 20:10

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

HSY closed Friday at $165.61, up 3.3% on the day after reporting Q3 results on October 29. That single-session recovery, however, still leaves the stock down 2.4% on the week, underperforming most of its closest peers. MDLZ gained 1.8% over the same period and CPB rose 3.3%. The rebound came after a bruising run: the stock had dropped sharply ahead of and through the Q3 print, and the analyst community responded by marking targets lower across the board on October 30.

The October 30 analyst action is the clearest signal of where the Street stands. TD Cowen's Robert Moskow downgraded Hershey to Hold from Buy, cutting his target to $173 from $198, citing market share losses in core chocolate to Mars. Five other firms cut targets the same day without changing their ratings: RBC trimmed to $190, BNP Paribas to $190, Wells Fargo to $160, and Evercore ISI to $200. The consensus is now 5 buys against 15 holds, with a mean target of $186.90, roughly 13% above Friday's close. The bear case is concrete. Hershey lost about 115 basis points of dollar share and 190 basis points of volume share in Q2 2026 as Mars took ground through wider price gaps and large-format value packs. Cocoa futures near $5,600 per ton constrain pricing flexibility, and recent launches outside Reese's Oreo have shown weak repeat rates. The bull case rests on Hershey's 35%-plus share of the domestic chocolate aisle, scale advantages, and management's target of 2 to 4% organic growth alongside stronger EPS recovery in 2026 to 2028.

Short interest and the lending market are less dramatic than the analyst moves suggest. Shorts rebuilt modestly through the week, with short interest rising about 3% over seven days to reach 6.2% of the free float, or around 9.2 million shares. That is a meaningful position, but not an extreme one. Availability remains very loose at 813%, meaning roughly eight shares are available to borrow for every one already lent out. Cost to borrow ticked up 18% on the week to 0.53%, but that is still a low absolute rate with no squeeze pressure in the lending pool. Options positioning, by contrast, has turned more defensive than usual. The put/call ratio rose to 0.84, almost 2.5 standard deviations above its 20-day average of 0.78. That is a sharp shift from the pre-earnings setup described in the October 26 note, when the PCR was running below its average. Options traders have repriced their hedging demand materially since the print.

Hershey's largest single holder, the Milton Hershey School Trust, has been selling steadily this week under a pre-arranged 10b5-1 plan. The Trust, which holds around 27.4% of total shares, sold roughly 30,000 shares across multiple tranches between October 26 and October 28 at prices in the $163 to $168 range. These are planned sales, not discretionary signals, and the Trust's structural dominance of the shareholder register means its slow reduction is mechanical rather than indicative of a change in view. The 90-day net across all insider activity is negative $23.4 million. Capital International Investors, which had held more than 6% of the class, has since filed a 13G/A showing its position reduced to near zero. Vanguard Capital Management carries a 13G at 7.51% as last disclosed in April. As the disclosure note states, stakes are as last disclosed and holders dropping below 5% may exit without further filing.

The ORTEX alt data layer shows one notable fact: Hershey ran its largest Q2 buyback spend on record at $370 million, while remaining buyback authorisation fell to its smallest Q2 level in three years at $270 million. Wikipedia retail attention is running at a z-score of 3.1 against its own 90-day history, well above the norm, reflecting the elevated public interest around the Q3 results week. None of the three alt data datasets carry a measured lead against Hershey's reported figures, so no read-through to the next print is warranted.

The next scheduled earnings event is November 5. What that release will settle is less whether Hershey can still grow and more whether the chocolate aisle share losses are stabilising or accelerating into the back half of 2026.

Stocks in this article

See the live data behind this article on ORTEX.

Open HSY on ORTEX →

How this article was generated

Generated
31 Oct 2026, 20:14
Data as of
31 Oct 2026, 20:10
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.